Effect of Cystatin C on Vancomycin Clearance Estimation in Critically Ill Children Using a Population Pharmacokinetic

Kevin J Downes1,2,3,4, Nicole R Zane1, Athena F Zuppa1,5,6

  • 1The Center for Clinical Pharmacology, Children's Hospital of Philadelphia.

Therapeutic Drug Monitoring
|September 18, 2020
PubMed

Insights

Cystatin C (CysC)-based equations provide a more accurate estimation of vancomycin clearance in critically ill children compared to the standard bedside Schwartz equation, improving drug dosing and patient care.

Area of Science:

  • Pediatric Critical Care Medicine
  • Pharmacokinetics and Drug Metabolism
  • Renal Function Assessment

Background:

  • Vancomycin elimination relies on glomerular filtration, but current methods for estimating kidney function in children are often unreliable.
  • Accurate estimation of glomerular filtration rate (GFR) is crucial for optimizing vancomycin dosing in pediatric patients.
  • The study addresses the limitations of traditional creatinine-based GFR estimations in critically ill children.

Purpose of the Study:

  • To compare the performance of cystatin C (CysC)-based glomerular filtration rate (GFR) equations against the bedside Schwartz creatinine-based equation.
  • To determine the most suitable method for estimating vancomycin clearance (CL) in critically ill pediatric patients.
  • To enhance the accuracy of vancomycin dosing through improved GFR estimation.

Main Methods:

  • A prospective observational study involving critically ill children (2-18 years) receiving intravenous vancomycin.
  • Collection of vancomycin levels and plasma cystatin C (CysC) measurements.
  • Nonlinear mixed-effects modeling (NONMEM) to evaluate the impact of estimated GFR (eGFR) on vancomycin CL, comparing CysC-based equations with the bedside Schwartz equation.

Main Results:

  • A 1-compartment model with allometric scaling best described vancomycin pharmacokinetics.
  • Inclusion of eGFR derived from CysC-based equations significantly improved the pharmacokinetic model fit compared to the bedside Schwartz equation.
  • An eGFR equation incorporating both creatinine and CysC yielded the greatest improvement in model fit, indicating superior accuracy.

Conclusions:

  • Cystatin C (CysC)-based equations offer a more precise estimation of vancomycin clearance (CL) in critically ill children than the bedside Schwartz equation.
  • These findings support the use of CysC-based GFR estimations for optimizing vancomycin therapy in pediatric intensive care settings.
  • Improved GFR estimation using CysC can lead to more accurate vancomycin dosing and potentially better patient outcomes.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
131
Clearance Models: Compartment Models01:25

Clearance Models: Compartment Models

Clearance measures drug elimination from the central compartment, including plasma and highly perfused organs like kidneys and liver. Its calculation varies depending on pharmacokinetic models and administration routes. The one-compartment model, for instance, portrays the pharmacokinetics of polar drugs such as aminoglycoside antibiotics administered intravenously and readily excreted in urine. In this case, clearance is influenced by the terminal rate constant (λz) and the total volume...
226
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
108
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
114
One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance00:56

One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance

Clearance is a key pharmacokinetic parameter that quantifies the volume of body fluid from which a drug is entirely removed within a specific time frame. It is crucial in assessing how a drug is eliminated from the body and has critical clinical applications.
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
233
Clearance Models: Noncompartmental Models01:17

Clearance Models: Noncompartmental Models

Clearance is a pharmacokinetic parameter traditionally defined by compartment models, signifying the rate at which a drug is expelled from the body. However, a noncompartmental model offers an alternative method for assessing clearance, primarily employing empirical data obtained after administering a single drug dose.
The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...
162